Correction to: MET receptor serves as a promising target in melanoma brain metastases

Affiliations

• ¹ Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria. torben.redmer@vetmeduni.ac.at.
• ² Institute of Pathology, Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria. torben.redmer@vetmeduni.ac.at.
• ³ Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
• ⁴ German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Berlin, Germany.
• ⁵ Institute of Pathology, University Medicine Greifswald, Greifswald, Germany.
• ⁶ Department of Neurosurgery, University Medicine Greifswald, Greifswald, Germany.
• ⁷ Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria.
• ⁸ Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
• ⁹ Nutrigenomics Unit, Institute of Animal Nutrition and Functional Plant Compounds, University of Veterinary Medicine Vienna, Vienna, Austria.
• ¹⁰ Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
• ¹¹ Institute of Pathology, University Medicine Greifswald, Greifswald, Germany. josefine.radke@med.uni-greifswald.de.